Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
xuebijing (1 trial)
IMMH-010 (1 trial)
kukoamine b (4 trials)
Neoplasms (Phase 2)
Sepsis (Phase 4)
Toxemia (Phase 4)
Trials (6 total)
Trial APIs (3 total)